BioNTech | Latin Post - Latin news, immigration, politics, culture

BioNTech Strikes Cancer Vaccine Deal, Thousands to Take Part in Cancer Vaccine Trials

BioNTech Is Creating Cancer Vaccine With UK's Help; Cancer Vaccine Trials Could Start as Early as September

Pharmaceutical firm BioNTech has struck a deal with the United Kingdom to develop a cancer vaccine, with cancer vaccine trials expected to start as early as September.

Pfizer Executive 'Shockingly' Admits COVID-19 Vaccine Was Never Tested on Preventing Transmission Before Release

Oct 12, 2022 06:01 AM EDT By Mary Webber

A Pfizer executive admitted that she and other Pfizer officials did not know whether the company's COVID-19 vaccine would stop viral transmission before being publicly distributed last year.

CDC Recommends Pfizer COVID Vaccine Boosters for Children as Young as 12

Jan 05, 2022 10:56 PM EST By Joshua Summers

An advisory panel to the Centers for Disease Control and Prevention (CDC) recommended a Pfizer-BioNTech COVID-19 vaccine booster dose among youth aged 12-15.

Pfizer Says 2 Shots of COVID Vaccine Plus Booster Raises Protection Against Omicron Variant

Dec 09, 2021 01:06 AM EST By Mary Webber

Pfizer-BioNTech said two-dose of their COVID vaccine, along with a booster shot, could provide protection against the new Omicron variant.

Americans Will Get COVID-19 Vaccine Free of Charge, US Government Says

Jul 23, 2020 01:05 AM EDT By Millicent Young

The vaccine showed promising results in developing antibodies that are seen in recovered patients.

COVID-19 Human Trials: Updates of Companies Working on Vaccines

Apr 10, 2020 07:30 AM EDT By Neil P.

In the past weeks, pharmaceutical and biotech companies have aimed to develop COVID-19 vaccines, which are now scheduled for human trials. Read on to find out how far each company has gone.